Literature DB >> 33966558

Endovascular treatment of extracranial carotid artery stenosis using a dual-layer micromesh stents: a systematic review.

Daniela Mazzaccaro1, Matteo Giannetta1, Fabiana Fancoli1, Paolo Righini1, Giovanni Nano1,2.   

Abstract

Introduction: We aimed to review the safety and effectiveness of dual-layer micromesh stents for the endovascular treatment of carotid artery stenosis.
Methods: Electronic bibliographic databases were searched using the words 'micromesh carotid stent'. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards.
Results: The search of the Literature retrieved 84 results. After assessment of full texts, 13 papers were included in the study. The analyzed studies included 797 patients, 32.1% of them were symptomatic. The reported technical success rate was 100% in all cases. During early follow-up, complications occurred overall in 16/797 patients (2%: 12 strokes, 3 deaths, and one transient ischemic attack). The study with the longest follow-up reported a survival rate of 82% at 4 years and a stroke-free survival rate of 84% at 4 years.
Conclusion: With the limit of low data quality, the use of dual-layer stents was reported to be as safe and effective at 30 days for the endovascular treatment of extracranial carotid artery stenosis. The reported technical success was 100% in all cases. Further data coming from randomized controlled trials and larger cohort studies with longer follow-up are nevertheless needed for a better evaluation.

Entities:  

Keywords:  Carotid stenting; c-guard; carotid stenosis; dual-layer; micromesh; nitinol stent; roadsaver

Year:  2021        PMID: 33966558     DOI: 10.1080/17434440.2021.1927707

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  1 in total

1.  "Real-World Study of a Dual-Layer Micromesh Stent in Elective Treatment of Symptomatic and Asymptomatic Carotid Artery Stenosis (ROADSAVER)".

Authors:  Sasko Kedev; Stefan Müller-Hülsbeck; Ralf Langhoff
Journal:  Cardiovasc Intervent Radiol       Date:  2022-01-18       Impact factor: 2.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.